相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ultrasound and radiology surrogate endpoints in pharmacological studies
S. Agewall et al.
ATHEROSCLEROSIS (2012)
Comparison of tumor response by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinoma
Julien Edeline et al.
CANCER (2012)
Predicting survival in patients with hepatocellular carcinoma treated by transarterial chemoembolisation
G. Cabibbo et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Changes in Tumor Density in Patients with Advanced Hepatocellular Carcinoma Treated with Sunitinib
Sandrine Faivre et al.
CLINICAL CANCER RESEARCH (2011)
Radiographic Response to Locoregional Therapy in Hepatocellular Carcinoma Predicts Patient Survival Times
Khairuddin Memon et al.
GASTROENTEROLOGY (2011)
Field-Practice Study of Sorafenib Therapy for Hepatocellular Carcinoma: A Prospective Multicenter Study in Italy
Massimo Iavarone et al.
HEPATOLOGY (2011)
Clinical Decision Making and Research in Hepatocellular Carcinoma: Pivotal Role of Imaging Techniques
Jordi Bruix et al.
HEPATOLOGY (2011)
Survival After Yttrium-90 Resin Microsphere Radioembolization of Hepatocellular Carcinoma Across Barcelona Clinic Liver Cancer Stages: A European Evaluation
Bruno Sangro et al.
HEPATOLOGY (2011)
Management of Hepatocellular Carcinoma: An Update
Jordi Bruix et al.
HEPATOLOGY (2011)
EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolisation
Roopinder Gillmore et al.
JOURNAL OF HEPATOLOGY (2011)
Interobserver and intraobserver variability in the response evaluation of cancer therapy according to RECIST and WHO-criteria
Chikako Suzuki et al.
ACTA ONCOLOGICA (2010)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Hepatocellular Carcinoma: Epidemiology, Surveillance, and Diagnosis
Morris Sherman
SEMINARS IN LIVER DISEASE (2010)
Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
Riccardo Lencioni et al.
SEMINARS IN LIVER DISEASE (2010)
Evaluation of Tumor Response After Locoregional Therapies in Hepatocellular Carcinoma Are Response Evaluation Criteria in Solid Tumors Reliable?
Alejandro Forner et al.
CANCER (2009)
Hepatocellular Cancer: Optimal Strategies for Screening and Surveillance
Giuseppe Cabibbo et al.
DIGESTIVE DISEASES (2009)
Treatment of advanced hepatocellular carcinoma with long-acting octreotide: A phase III multicentre, randomised, double blind placebo-controlled study
Jean-Claude Barbare et al.
EUROPEAN JOURNAL OF CANCER (2009)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Design and endpoints of clinical trials in hepatocellular carcinoma
Josep M. Llovet et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Long acting octreotide in the treatment of advanced hepatocellular cancer and overexpression of somatostatin receptors: Randomized placebo-controlled trial
D. Dimitroulopoulos et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: Proposal of new computed tomography response criteria
Haesun Choi et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Long-acting octreotide versus placebo for treatment of advanced HCC:: A randomized controlled double-blind study
Gerhild Becker et al.
HEPATOLOGY (2007)
Drug development in oncology: classical cytotoxics and molecularly targeted agents
Shivaani Kummar et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2006)
RECIST revisited: A review of validation studies on tumour assessment
P. Therasse et al.
EUROPEAN JOURNAL OF CANCER (2006)
Management of hepatoceullular carcinoma
J Bruix et al.
HEPATOLOGY (2005)
Randomized controlled trial of tamoxifen in advanced hepatocellular carcinoma
JC Barbare et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA):: a prospective study
C Cammà et al.
JOURNAL OF HEPATOLOGY (2005)
Interobserver and intraobserver variability in measurement of non-small-cell carcinoma lung lesions: Implications for assessment of tumor response
JJ Erasmus et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
High-dose tamoxifen in the treatment of inoperable hepatocellular carcinoma: A multicenter randomized controlled trial
PKH Chow et al.
HEPATOLOGY (2002)
A randomized placebo-controlled study of long-acting octreotide for the treatment of advanced hepatocellular carcinoma
MF Yuen et al.
HEPATOLOGY (2002)
Measuring the clinical response. What does it mean?
P Therasse
EUROPEAN JOURNAL OF CANCER (2002)
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma:: a randomised controlled trial
JM Llovet et al.
LANCET (2002)
Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma
CM Lo et al.
HEPATOLOGY (2002)
Clinical management of hepatocellular carcinoma.: Conclusions of the Barcelona-2000 EASL Conference
J Bruix et al.
JOURNAL OF HEPATOLOGY (2001)
Hormonal therapy with megestrol in inoperable hepatocellular carcinoma characterized by variant oestrogen receptors
E Villa et al.
BRITISH JOURNAL OF CANCER (2001)
Improved survival with oral administration of enteric-coated tegafur/uracil for advanced stage IV-A hepatocellular carcinoma
T Ishikawa et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2001)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma
JM Llovet et al.
HEPATOLOGY (2000)
分享论文
